Related Experiment Videos
Fluid and electrolyte therapy and chronic lung disease
1Department of Pediatrics, College of Physicians and Surgeons, Columbia University, New York, New York 10032, USA. jl1084@columbia.edu
Current Opinion in Pediatrics
|March 17, 2004
Summary
Current evidence is insufficient to link fluid and electrolyte therapy to chronic lung disease development. While fluid balance in preterm infants is critical, optimal levels for reducing chronic lung disease risk remain unclear.
Area of Science:
- Neonatology
- Pediatric Pulmonology
- Critical Care Medicine
Background:
- Chronic lung disease (CLD) is a significant concern in premature infants.
- Fluid and electrolyte balance is a critical aspect of neonatal care.
Purpose of the Study:
- To evaluate the role of fluid and electrolyte therapy in the pathogenesis of chronic lung disease.
- To assess the impact of fluid intake and water balance on CLD development.
Main Methods:
- Review of observational studies and meta-analysis of randomized controlled trials.
- Analysis of data on fluid intake, body water balance, and sodium intake in relation to CLD.
Main Results:
- Observational studies suggest an association between increased fluid intake/altered water balance and CLD.
- A meta-analysis of three trials found no significant increase in CLD risk with higher fluid intakes.
- Conflicting results exist regarding the impact of sodium intake on CLD prevalence.
Conclusions:
- Insufficient evidence to establish fluid and electrolyte therapy's role in CLD pathogenesis.
- Optimal fluid and electrolyte management strategies for reducing CLD risk in infants are not defined.
- Negative fluid and sodium balance may be physiological in preterm infants, while positive balance may increase morbidity.